Newest by Date
Newest by Title
Oldest by Date
Oldest by Title
How Long Will a Vaccine Really Take?
A vaccine would be the ultimate weapon against the coronavirus and the best route back to normal life.
The search for life sciences solutions to the COVID-19 crisis
Helping to accelerate CROs that are working tirelessly and providing value to the clinical trial ...
Reimagine clinical trials with open approaches and interoperability
Read about our open technology philosophy and how it could increase patient engagement.
The future of clinical trials is now
Given the enormous investment that the life sciences industry makes in drug development and the regulatory complexity of the work, it is not surprising that the adoption of novel approaches has been slow.
Using real-world data to build a learning healthcare system
With more diverse real-world data (RWD), life sciences companies recognize the value of using the right data framework, asking the right questions and engaging expertise.
The pharmaceutical industry’s shift from big data to broad data and AI
From single tasks to enterprise-level challenges, life science companies are using AI to help ...
5 pharma trends to watch in 2020
Keep a watch on these 5 industry trends. New technology and data are here to stay. Are you keeping track of the ways it’s changing clinical development? Read this blog from Watson Health leader Mary Varghese Presti sharing her thoughts on 2020 ...
Value-based healthcare, a 2020 outlook
The IBM Institute for Business Value (IBV) and IBM Watson Health recently conducted a study of healthcare payers and providers to determine what is needed to transition to an inclusive, value-based health system – integrating technology to ...
IBM Watson Health has participated in conversations that help policymakers better understand the real-world impact of these standards and regulations. To tackle the “how,” we approach three essential domains to help accelerate the transformation ...
Data: friend, foe or both? How life sciences leaders can benefit from data proliferation
Companies could benefit from using the wealth of intelligence to optimize the product development ...
Applauding Interoperability Improvements
At IBM, we strongly believe that all citizens have a right to improved information flow between the various clinicians they see.
Making the Promise of Smarter Health a Reality
The true value of data flowing through physicians' offices and public health departments has gone untapped because it is unstructured and siloed in systems that don’t talk to one another.